From Scientific Invention to Cancer Moonshot Innovation
Innovation is a serendipitous journey incubated with deligient, focus and decades of expertise. Our story is no different.
The Brain of Our Innovation
Dr. Hai HU
Founder of miRoncol diagnostics
Dr. Hu is the key inventor of the diagnostics model that is the foundation of miRoncol. With his insight on the disruption and positive impact the invention can bring to cancer moonshot, he turned himself into a passionate entrepreneur dedicated to commercialize the technology.
Experienced leader in bioinformatics
Dr. Hu has served as the Chief Scientific Officer of Chan Soon-Shiong Institute of Molecular Medicine at Windber since 2008 after demonstrating decades of exceptional academic excellence and leadership. He oversees all scientific activities including bioinformatics, informatics infrastructure, biobanking, and molecular research.
TCGA recipients of the 2020 Team Science Award from the American Association for Cancer Research
Winner of the 2021 James J. Leonard Award for Excellence in Clinical/Translational Research.
Award-winning bioinformatics scientist on cancer research
Dr. Hu focuses his research on breast cancer and pan-cancers taking an integrative approach using data from multiple clinical and molecular platforms.
He has published over 80 peer-reviewed papers including ones in Cell and Nature. He also has published five book chapters and co-edited two books. He has presented at many national and international scientific and business conferences, delivering keynote speeches and serving as bioinformatics program or session chair in several of them.
Dr. Hu obtained his PhD in Biophysics from SUNY Buffalo and completed a post-doctoral training at the Johns Hopkins School of Medicine.
Widely recognized thought leader in scientific communities
Dr. Hu serves on the Council of the John P. Murtha Cancer Center, and the Scientific Committee of the Center for Prostate Disease Research of Uniformed Services University of the Health Sciences. He is a member and leader of several major cancer research consortiums including The Cancer Genome Atlas (TCGA) Research Network, and the Applied Proteogenomic OrganizationaL Learning and Outcomes (APOLLO).